About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Aqp4tm1.1Lmno
targeted mutation 1.1, Laboratory for Molecular Neuroscience
MGI:4946403
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Aqp4tm1.1Lmno/Aqp4tm1.1Lmno B6.Cg-Aqp4tm1.1Lmno MGI:4946419


Genotype
MGI:4946419
hm1
Allelic
Composition
Aqp4tm1.1Lmno/Aqp4tm1.1Lmno
Genetic
Background
B6.Cg-Aqp4tm1.1Lmno
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aqp4tm1.1Lmno mutation (0 available); any Aqp4 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• basal brain water content is increased compared to in wild-type mice
• mutants infected with P. berghei ANKA show greater brain water content than infected wild-type mice, despite a similar level of blood-brain barrier disruption
• under 20% reduced osmolarity, astrocytes exhibit decreased increase in soma volume compared with similarly treated wild-type cells
• following water injection, astrocytes exhibit impaired calcium response and ATP release compared with similarly treated wild-type cells
• however, soma volume increase under a 30% reduction in osmolarity is normal

cardiovascular system
• basal brain water content is increased compared to in wild-type mice

homeostasis/metabolism
• mutants infected with P. berghei ANKA show greater brain water content than infected wild-type mice, despite a similar level of blood-brain barrier disruption

immune system
• mice infected with Plasmodium berghei ANKA exhibit an earlier appearance of cerebral malaria than wild-type mice, showing reduced mobility, ruffled coat, hunched back, or coma, and increased width of perivascular astrocyte end-feet
• mutants infected with P. berghei ANKA show greater brain water content than infected wild-type mice, despite a similar level of blood-brain barrier disruption
• by the 6th day following P. burghei ANKA infection, mutants show a greater reduction in survival than infected wild-type mice (about 32% survival versus about 86% survival in wild-type mice)
• administration of chloroquine beginning on the morning of day 6 of P. burghei ANKA infection, results in only a 20% survival of mutants compared to 70% survival in wild-type mice by day 15 of treatment

mortality/aging
• by the 6th day following P. burghei ANKA infection, mutants show a greater reduction in survival than infected wild-type mice (about 32% survival versus about 86% survival in wild-type mice)
• administration of chloroquine beginning on the morning of day 6 of P. burghei ANKA infection, results in only a 20% survival of mutants compared to 70% survival in wild-type mice by day 15 of treatment

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
malaria DOID:12365 J:193622





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory